Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This trial seeks to accomplish both local and regional control of head and neck cancer and
reduce systemic metastatic disease. To do this, patients will received chemotherapy followed
by chemotherapy and radiation (given together) with an escalating dose of docetaxel.